Tylenol for Adults Cold + Flu Severe is a combination medication used to treat symptoms of the common cold and flu, including cough, fever, headache, sore throat, and nasal congestion. It contains acetaminophen to reduce fever and relieve pain, as well as dextromethorphan, phenylephrine, and guaifenesin to suppress cough, alleviate nasal congestion, and thin and loosen mucus.
Benefits:
Relieves Cold and Flu Symptoms
Tylenol for Adults Cold + Flu Severe provides relief from a wide range of cold and flu symptoms, including cough, fever, headache, sore throat, and nasal congestion.
Contains Acetaminophen
Acetaminophen is an effective pain reliever and fever reducer that can help to alleviate the discomfort associated with cold and flu symptoms.
Includes Cough Suppressant, Nasal Decongestant, and Expectorant
The addition of dextromethorphan, phenylephrine, and guaifenesin to this medication provides relief from cough, nasal congestion, and mucus buildup, respectively.
Convenient Caplet Form
Tylenol for Adults Cold + Flu Severe comes in a caplet form, making it easy to take and swallow.
Long-Lasting Relief
This medication provides relief for up to 8 hours, allowing you to get the rest and relief you need.
About the Product:
Tylenol for Adults Cold + Flu Severe is a powerful medication that provides relief from a wide range of cold and flu symptoms. Its combination of active ingredients works together to relieve pain, reduce fever, suppress cough, alleviate nasal congestion, and thin and loosen mucus.
How to Use:
Take 2 caplets every 6 hours as needed. Do not take more than 8 caplets in 24 hours.
Ingredients:
Acetaminophen 325 mg, dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCl 5 mg.
Caution:
Do not take more than the recommended dose. This medication may cause liver damage if taken in excess. Do not take this medication if you are allergic to any of the ingredients. If symptoms persist, consult your doctor. Keep out of reach of children.
Legal Disclaimer:
Made in the USA
Reviews
There are no reviews yet.